Ticagrelor, a new antiplatelet agent, for prevention of ischemic events in patients with coronary artery disease.
Adams
Harold P
HP
Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa Stroke Center, University of Iowa, 200 Hawkings Drive, Iowa City, IA, 52242, USA. harold-adams@uiowa.edu
D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000150:complications*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007511:Ischemia / Q000209:etiology* / Q000517:prevention & control*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016016:Proportional Hazards Models; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine